Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1994BloodOpen Access

A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWeixing LiChinese Academy of SciencesKAKaplan AvDartmouth–Hitchcock Medical CenterGGGW GrantStanford University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (1994) studied this question.

synapsesocial.com/papers/6a210d91bbda06802a96787fhttps://doi.org/10.1182/blood.v83.3.677.677
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis1989 · 117 citations
  2. 2Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.1989 · 207 citations
  3. 3Importance of factor Xa in determining the procoagulant activity of whole-blood clots.1993 · 153 citations
  4. 4Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.1988 · 243 citations
  5. 5In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits1993 · 278 citations